Adverse events reported by > 5% of subjects.
| Adverse Event | n (%) |
|---|---|
| Nasopharyngitis | 20 (18.2) |
| Upper respiratory tract infection | 15 (13.6) |
| Injection site reaction | 13 (11.8) |
| Headache | 12 (10.9) |
| Influenza-like illness | 11 (10.0) |
| Sinusitis | 11 (10.0) |
| Diarrhea | 7 (6.4) |
| Hypertension | 7 (6.4) |
| Arthralgia | 6 (5.5) |
| Cough | 6 (5.5) |
| Pharyngolaryngeal pain | 6 (5.5) |